JPMORGAN CHASE & CO - DYNE THERAPEUTICS INC ownership

DYNE THERAPEUTICS INC's ticker is DYN and the CUSIP is 26818M108. A total of 84 filers reported holding DYNE THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.6%.

Quarter-by-quarter ownership
JPMORGAN CHASE & CO ownership history of DYNE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$3,030,039
+656.3%
338,174
+849.6%
0.00%
Q2 2023$400,635
+29.7%
35,612
+32.5%
0.00%
Q1 2023$309,000
+130279.7%
26,869
+31.4%
0.00%
Q4 2022$237
-100.0%
20,444
-53.3%
0.00%
Q3 2022$557,000
+130.2%
43,776
+23.9%
0.00%
Q2 2022$242,000
-9.7%
35,320
+26.8%
0.00%
Q1 2022$268,000
-40.4%
27,858
-26.4%
0.00%
Q4 2021$450,000
-70.4%
37,838
-59.6%
0.00%
Q3 2021$1,522,000
+355.7%
93,683
+491.1%
0.00%
Q2 2021$334,000
+111.4%
15,848
+55.8%
0.00%
Q1 2021$158,000
+17.9%
10,169
+59.4%
0.00%
Q4 2020$134,0006,3800.00%
Other shareholders
DYNE THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
MPM ASSET MANAGEMENT LLC 4,951,303$103,977,00014.71%
Vida Ventures Advisors, LLC 2,960,046$62,161,00012.76%
Octagon Capital Advisors LP 481,538$10,112,0003.50%
Logos Global Management LP 1,604,392$33,692,0002.89%
RA Capital Management 2,805,045$58,906,0000.82%
BOGLE INVESTMENT MANAGEMENT L P /DE/ 12,048$253,0000.40%
HighVista Strategies LLC 23,760$499,0000.32%
Vivo Capital, LLC 315,000$6,615,0000.30%
Woodline Partners LP 490,986$10,311,0000.27%
EcoR1 Capital, LLC 215,000$4,515,0000.24%
View complete list of DYNE THERAPEUTICS INC shareholders